This article by WIRED magazine describes work at Gladstone by Bruce Conklin, Jennifer Doudna, and Todd McDevitt to establish the epicenter of a whole new field of medicine: genome surgery. Their efforts are perhaps the most concentrated push in a national effort to create the tools and rules necessary for doctors to widely adopt genome editing as part of standard care for the 25 million Americans estimated to be living with one of 6,000 diseases caused by a glitch in their DNA.
Good Morning America
Jennifer Doudna expresses concern that a scientist claiming to have created the first gene-edited babies broke from the international consensus within the scientific community calling for an open and transparent approach for any clinical use of human embryo editing.
NIH Director's Blog
In his blog, NIH Director Francis Collins describes work by Bruce Conklin. He and his colleagues at UC Berkeley developed a new model that can mimic different degrees of stress that the heart may experience, for example, during exercise or in a person with high blood pressure.
Medium / UCSF Magazine
This post on Medium describes efforts at Gladstone by Jennifer Doudna and Bruce Conklin to bring CRISPR genome editing tools into the clinic to cure disease using an approach coined “genome surgery.”
The Washington Post
Many scientists are urging a halt to clinical trials that were based partly on falsified data published by a prominent researcher from Harvard Medical School. Deepak Srivastava comments to The Washington Post that it’s time to pause and evaluate such trials.
The New York Times
As a story broke out of Harvard Medical School and Brigham and Women’s Hospital involving the falsification of scientific data by Piero Anversa, Benoit Bruneau remarked to The New York Times that this could put into question an entire field of study.
CBS New York
CBS New York covers a breakthrough by Yadong Huang, who’s looking at a gene—called apoE4—he and his team believe increases the risk for developing Alzheimer's.
The Stem Cellar, CIRM
This blog post highlights a CIRM-funded scientific collaboration between UC Berkeley and Bruce Conklin at Gladstone, during which the researchers found a better way to study certain heart diseases by generating a 3D model of heart tissue.
San Francisco Business Times
The San Francisco Business Times explores the latest approaches to an HIV cure by companies and academic researchers. “‘Cure’ overpromises what we can do right now. But the idea of a cure has helped to shape the field,” says Warner Greene.
In this Time Magazine article that dives into new possible stem cell and regenerative therapies, Deepak Srivastava talks about his research and how stem cells offer a new way to get to the root cause of a disease and start looking for cures.